(Total Views: 436)
Posted On: 01/12/2021 4:12:35 PM
Post# of 145890
I can agree in terms of dosing, RO would be in the domain of P4. As an efficacy predictor, RO would have been great to have in P3.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)